Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of roxadustat vs darbepoetin alfa for anemia in non-dialysis chronic kidney disease
2013-000951-42Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of roxadustat in anemia of renal disease and anaemia (2 arms), sponsored by Astellas Pharma. Primary endpoint: Primary hemoglobin response. Started Sep 2013; status: completed.
02
Drugs
roxadustat
03
Conditions
anemia of renal diseaseanaemia
Beyond the preview
Go deeper on 2013-000951-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000951-42.